港股異動 | 中國中免(1880.HK)跌逾5% 富瑞料其Q3淨利同比下跌45%
格隆匯10月19日丨中國中免(1880.HK)現跌5.27%報183.2港元,暫成交5787萬港元,最新市值3790億港元。富瑞近日發報告指,基於預期銷售下跌20%,預料中國中免Q3淨利潤下跌45%至17億元人民幣,而由於疫情影響,預料公司Q3海南地區銷量同比下跌27%。該行表示,對中國中免2022年至24年銷量預測分別下調3%、2%及2%,故將其淨利潤預測分別下調5%、3%、3%,同時將其目標價由247.3港元下調至235.9港元,維持買入評級。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.